<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T08:50:29Z</responseDate>
  <request identifier="oai:figshare.com:article/33997981" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33997981</identifier>
        <datestamp>2026-09-25T17:26:23Z</datestamp>
        <setSpec>category_21</setSpec>
        <setSpec>category_24</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Industry-sponsored research payments (ISRPs) to physician principal investigators (PIs) in the United States, overall and by specialty, from 2016 to 2022.&lt;/p&gt;</dc:title>
          <dc:creator>Zhuo Tony Su (25111147)</dc:creator>
          <dc:creator>Zeyad Hammadeh (25111150)</dc:creator>
          <dc:creator>Logan B. Galansky (25111153)</dc:creator>
          <dc:creator>Alyssa G. Arbuiso (7320233)</dc:creator>
          <dc:creator>Yuezhou Jing (11570561)</dc:creator>
          <dc:creator>Bruce J. Trock (11054043)</dc:creator>
          <dc:creator>Misop Han (843059)</dc:creator>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Evolutionary Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>require specific disclosure</dc:subject>
          <dc:subject>largest payment category</dc:subject>
          <dc:subject>5 %) directed</dc:subject>
          <dc:subject>2016 &amp;# 8211</dc:subject>
          <dc:subject>specific products investigated</dc:subject>
          <dc:subject>25 products associated</dc:subject>
          <dc:subject>open payments program</dc:subject>
          <dc:subject>particularly immunotherapy agents</dc:subject>
          <dc:subject>opp reporting rules</dc:subject>
          <dc:subject>industry financial relationships</dc:subject>
          <dc:subject>physician pis totaled</dc:subject>
          <dc:subject>physician pis receiving</dc:subject>
          <dc:subject>sponsored research payments</dc:subject>
          <dc:subject>physician pis directly</dc:subject>
          <dc:subject>sponsored research</dc:subject>
          <dc:subject>experimental products</dc:subject>
          <dc:subject>physician pis</dc:subject>
          <dc:subject>led research</dc:subject>
          <dc:subject>extensive research</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>used publicly</dc:subject>
          <dc:subject>teaching hospitals</dc:subject>
          <dc:subject>study highlights</dc:subject>
          <dc:subject>secondary measures</dc:subject>
          <dc:subject>scrutinized general</dc:subject>
          <dc:subject>relatively understudied</dc:subject>
          <dc:subject>recipient types</dc:subject>
          <dc:subject>promote transparency</dc:subject>
          <dc:subject>originally intended</dc:subject>
          <dc:subject>organizations referred</dc:subject>
          <dc:subject>observational study</dc:subject>
          <dc:subject>nces ]).</dc:subject>
          <dc:subject>medical specialties</dc:subject>
          <dc:subject>improved disclosures</dc:subject>
          <dc:subject>identify cash</dc:subject>
          <dc:subject>general internists</dc:subject>
          <dc:subject>covered entities</dc:subject>
          <dc:subject>cancer drugs</dc:subject>
          <dc:subject>available data</dc:subject>
          <dc:subject>9 billion</dc:subject>
          <dc:subject>6 billion</dc:subject>
          <dc:subject>2013 following</dc:subject>
          <dc:description>&lt;p&gt;Industry-sponsored research payments (ISRPs) to physician principal investigators (PIs) in the United States, overall and by specialty, from 2016 to 2022.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-25T17:26:19Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0358886.t001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Industry-sponsored_research_payments_ISRPs_to_physician_principal_investigators_PIs_in_the_United_States_overall_and_by_specialty_from_2016_to_2022_p_/33997981</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
